---
title: "Stablecoins, AI-biotech could drive next VC wave: Insignia Ventures Partners"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292003237.md"
description: "Yinglan Tan of Insignia Ventures Partners identifies Vietnam and Malaysia as emerging Southeast Asian startup hubs alongside Singapore and Indonesia. He predicts that stablecoins, agentic payments, and AI-integrated biotech will drive the next venture capital wave following the current AI trend."
datetime: "2026-07-08T02:41:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292003237.md)
  - [en](https://longbridge.com/en/news/292003237.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292003237.md)
generator: "portal-rs"
---

# Stablecoins, AI-biotech could drive next VC wave: Insignia Ventures Partners

Yinglan Tan of Insignia Ventures Partners says that beyond Singapore and Indonesia, Vietnam and Malaysia are emerging as key startup hubs in Southeast Asia. He adds that following the AI wave, areas like stablecoins, agentic payments and AI's integration with biotech could attract venture capital investments.

### Related Stocks

- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IXJ.AU](https://longbridge.com/en/quote/IXJ.AU.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [3 healthcare ETFs to own in a choppy stock market](https://longbridge.com/en/news/291834343.md)
- [Roivant Sciences President & CIO Sold Shares Worth Over $24M](https://longbridge.com/en/news/296285296.md)
- [Great Lakes Advisors LLC Acquires Shares of 66,924 Ionis Pharmaceuticals, Inc. $IONS](https://longbridge.com/en/news/296455358.md)
- [Arrowstreet Capital discloses net short position in DBV Technologies](https://longbridge.com/en/news/296366886.md)
- [Keros Therapeutics director Jean Jacques Bieneaime acquires USD 10,270 in common shares](https://longbridge.com/en/news/296395349.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**